Bone Scan Index (BSI) of bone scintigraphy and detection of circulate tumor cells (CTC) are strong predictive factors on effectiveness of enzalutamide for castration-resistant prostate cancer with bone metastases
INTERNATIONAL JOURNAL OF UROLOGY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要